drugset / Trial / NCT06963580

Efficacy of MI078 Capsules in Treating Postpartum Depression

NCT06963580 ↗

Phase 2 Completed 72 enrolled Nanjing Minova Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled trial. It includes three groups. Each group will enroll 24 participants. The trial aims todetermine: To evaluate the efficacy of MI078 capsules in treating postpartum depression and to explore the optimal dosing regimen for MI078 capsules. To assess the safety of MI078 capsules in postpartum depression patients.

Timeline

Start
2024-09-09
Primary completion
2025-08-07
Completion
2025-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MI078 Unknown — —

Indications